122
Views
11
CrossRef citations to date
0
Altmetric
Articles

Lymphoproliferative Disease

, , , , , & show all
Pages 183-190 | Published online: 04 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Salah Aref, Y. Mossad, T. El-Khodary, M. Awad & E. El-Shahat. (2006) Cyclin D1 expression in B-cell non Hodgkin lymphoma. Hematology 11:5-6, pages 365-370.
Read now

Articles from other publishers (10)

Edward V. Prochownik & Huabo Wang. (2022) Normal and Neoplastic Growth Suppression by the Extended Myc Network. Cells 11:4, pages 747.
Crossref
Hitoshi Shibasaki, Hiroaki Kinoh, Horacio Cabral, Sabina Quader, Yuki Mochida, Xueying Liu, Kazuko Toh, Kazuki Miyano, Yu Matsumoto, Tatsuya Yamasoba & Kazunori Kataoka. (2021) Efficacy of pH-Sensitive Nanomedicines in Tumors with Different c-MYC Expression Depends on the Intratumoral Activation Profile. ACS Nano 15:3, pages 5545-5559.
Crossref
Wei Zhang, Qingru Zeng, Zhenying Ban, Jing Cao, Tianjiao Chu, Dongmei Lei, Chi Liu, Wentao Guo & Xianxu Zeng. (2018) Effects of let‑7c on the proliferation of ovarian carcinoma cells by targeted regulation of CDC25a gene expression. Oncology Letters.
Crossref
Jenan Al-Matouq, Thomas Holmes, Brianna Hammiller, Nicholas Tran, Matti Holmes, S. Caleb Freeman & Laura A. Hansen. (2017) Accumulation of cytoplasmic CDC25A in cutaneous squamous cell carcinoma leads to a dependency on CDC25A for cancer cell survival and tumor growth. Cancer Letters 410, pages 41-49.
Crossref
Weijing Cai, Chang Chen, Xinzheng Li, Jinyun Shi, Qian Sun, Di Liu, Yifeng Sun, Likun Hou, Xueying Zhao, Shaohua Gu, Qihan Wu, Hongyan Chen, Wei Zhang, Li Jin, Daru Lu, Ke Fei, Bo Su & Ji Qian. (2014) Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients. Future Oncology 10:7, pages 1175-1185.
Crossref
Zhe Zhang, Guojun Zhang & Chuize Kong. (2013) High expression of Cdc25B and low expression of 14-3-3σ is associated with the development and poor prognosis in urothelial carcinoma of bladder. Tumor Biology 35:3, pages 2503-2512.
Crossref
Jennifer EdelmannKarlheinz HolzmannFlorian MillerDirk WinklerAndreas BühlerThorsten ZenzLars BullingerMichael W. M. KühnAndreas GerhardingerJohannes BloehdornIna Radtke, Xiaoping Su, Jing MaStanley PoundsMichael HallekPeter LichterJan Korbel, Raymonde Busch, Daniel MertensJames R. Downing, Stephan StilgenbauerHartmut Döhner. (2012) High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 120:24, pages 4783-4794.
Crossref
Rose Boutros, Valérie Lobjois & Bernard Ducommun. (2007) CDC25 phosphatases in cancer cells: key players? Good targets?. Nature Reviews Cancer 7:7, pages 495-507.
Crossref
Alexander P. DucruetAndreas VogtPeter Wipf & John S. Lazo. (2005) DUAL SPECIFICITY PROTEIN PHOSPHATASES: Therapeutic Targets for Cancer and Alzheimer's Disease. Annual Review of Pharmacology and Toxicology 45:1, pages 725-750.
Crossref
Dirk L. Kienle, Christian Korz, Beate Hosch, Axel Benner, Daniel Mertens, Annett Habermann, Alexander Kröber, Ulrich Jäger, Peter Lichter, Hartmut Döhner & Stephan Stilgenbauer. (2005) Evidence for Distinct Pathomechanisms in Genetic Subgroups of Chronic Lymphocytic Leukemia Revealed by Quantitative Expression Analysis of Cell Cycle, Activation, and Apoptosis-Associated Genes. Journal of Clinical Oncology 23:16, pages 3780-3792.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.